Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat

Neuropharmacology

Volumn 39, Issue 10, 2000, Pages 1813-1822

  Béïque, Jean Claude ^a   Montigny, Claude De ^a   Blier, Pierre ^a   Debonnel, Guy ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT(1B) receptors; Adrenergic receptors; Antidepressant; Autoreceptors; Hippocampus; In vitro superfusion; Reuptake inhibitors

Indexed keywords

ADRENERGIC RECEPTOR; AUTORECEPTOR; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN 1B RECEPTOR; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; HIPPOCAMPUS; IN VITRO STUDY; MINIPUMP; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; AUTORECEPTORS; CARRIER PROTEINS; CRICETINAE; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PYRIDINES; PYRROLES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYMPORTERS; TIME FACTORS; TRITIUM;

EID: 0343963032     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00018-6     Document Type: Article

References (39)

1. Adell A., Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn-Schmiedeberg's Archives of Pharmacology. 343:1991;237-244.
2. Béïque J.C., Debonnel G., Blier P., de Montigny C. Effects of long-term administration of venlafaxine on the function of pre- and postsynaptic 5-HT and NE receptors in the rat hippocampus. Society of Neuroscience Abstracts. 24(2):1998;1363.
3. Béïque J.C., de Montigny C., Blier P., Debonnel G. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: A comparative study with paroxetine and desipramine. British Journal of Pharmacology. 125:1998;526-532.
4. Béïque J.C., Lavoie N., de Montigny C., Debonnel G. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. European Journal of Pharmacology. 349:1998;129-132.
5. Béïque J.C., de Montigny C., Blier P., Debonnel G. Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Synapse. 32:1999;198-211.
6. Bel N., Artigas F. Fluvoxamine preferentially increases extracellular 5- hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. European Journal of Pharmacology. 229:1992;101-103.
7. Benkert O., Grunder G., Wetzel H.et al. A randomized double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. Journal of Psychiatric Research. 30:1996;441-451.
8. Blier P., Bouchard C. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. British Journal of Pharmacology. 113:1994;485-495.
9. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends in Pharmalogical Sciences. 15:1994;220-226.
10. Blier P., Galzin A.M., Langer S.Z. Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus. Journal of Pharmacology and Experimental Therapeutics. 254:1990;236-244.
11. Bolden-Watson C., Richelson E. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Science. 52:1993;1023-1029.
12. Chaput Y., de Montigny C., Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat. Naunyn-Schmiedeberg's Archives of Pharmacology. 33:1986;342-349.
13. Chaput Y., de Montigny C., Blier P. Pre- and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments: An in vivo electrophysiological study in the rat. Neuropsychopharmacology. 5:1991;219-229.
14. de Montigny C., Silverstone P.H., Bakish D., Blier P., Debonnel G. Venlafaxine in treatment-resistant major depression: A Canadian multicentre open-label trial. Journal of Clinical Psychopharmacology. 19:1999;401-406.
15. El Mansari M., Bouchard C., Blier P. Alteration of serotonin release in the guinea pig orbito- frontal cortex by selective serotonin reuptake inhibitors - Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology. 13:1995;117-127.
16. Göthert M. Presynaptic 5-HT autoreceptors and the modulation of the release of 5-HT. Clinical Neuropharmacology. 9(4):1986;308-310.
17. Göthert M., Huth H. Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg's Archives of Pharmacology. 313:1980;21-26.
18. Göthert M., Huth M., Schlicker E. Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slice. Naunyn-Schmiedeberg's Archives of Pharmacology. 317:1981;199-203.
19. Guelfi J.D., White C., Magni G. A randomized, doule blind comparison of Venlafaxine and placebo in inpatients with major depression and melancholia. Clinical Neuropharmacology. 15:1992;19-168.
20. Kelsey J.E. Dose-response relationship with venlafaxine. Journal of Clinical Psychopharmacology. 16:1996;21S-28S.
21. Lacroix D., Blier P., Curet O., de Montigny C. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. Journal of Pharmacology and Experimental Therapeutics. 257:1991;1081-1090.
22. Langer S.Z. Presynaptic regulation of the release of catecholamines. Pharmacological Reviews. 32:1980;337-362.
23. Loftus D.J., Stolk J.M., U'Prichard D.C. Binding of the imidazoline UK-14, 304, a putative full alpha 2-adrenoceptor agonist, to rat cerebral cortex membranes. Life Science. 35:1984;61-69.
24. 1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. Journal of Medicinal Chemistry. 33:1990;2087-2093.
25. Maura G., Gemignani A., Raiteri M. Noradrenaline inhibits serotonin release through alpha-2 adrenoceptor located on serotonergic nerve terminals. Naunyn-Schmiedeberg's Archives of Pharmacology. 320:1982;272-274.
26. 2-adrenergic heteroreceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedeberg's Archives of Pharmacology. 347:1993;266-272.
27. 2 adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology. 10:1994;41-51.
28. Mongeau R., Weiss M., de Montigny C., Blier P. Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons. Neuropharmacology. 37:1998;905-918.
29. Moret C., Briley M. Serotonin autoreceptor subsensitivity and antidepressant activity. European Journal of Pharmacology. 180:1990;351-356.
30. Moret C., Briley M. Effect of milnacipran and desipramine on noradrenergic alpha 2-autoreceptor sensitivity. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 18:1994;1063-1072.
31. Muth E.A., Haskins J.T., Moyer J.A., Husbands G.E., Nielsen S.T., Sigg E.B. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochemical Pharmacology. 35:1986;4493-4497.
32. Nierenberg A.A., Feighner J.P., Rudolph R., Cole J.O., Sullivan J. Venlafaxine for treatment-resistant unipolar depression. Journal of Clinical Psychopharmacology. 14:1994;419-423.
33. Piñeyro G., Blier P., Dennis T., de Montigny C. Desensitization of the neuronal 5-HT carrier following its long-term blockade. Journal of Neuroscience. 14:1994;3036-3047.
34. Rueter L.E., Kasamo K., de Montigny C., Blier P. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 357:1998;600-610.
35. 2- and postsynaptic beta-adrenoceptor sensitivity in slices of rat neocortex after chronic treatment with various antidepressant drugs. Neuropharmacology. 23:1984;115-119.
36. 3H]5-hydroxytryptamine release from rat brain slices and its presynaptic α-adrenergic modulation after long-term desipramine pretreatment. Naunyn-Schmiedeberg's Archives of Pharmacology. 318:1982;173-180.
37. Schweizer E., Weise C., Clary C., Fox I., Rickels K. Placebo-controlled trial of venlafaxine for the treatment of major depression. Journal of Clinical Psychopharmacology. 11:1991;233-236.
38. Starke K., Göthert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiological Review. 69:1989;864-988.
39. 2-adrenoceptors in the rat hippocampus after long- term desipramine treatment. European Journal of Pharmacology. 294:1995;565-570.